Finerenone improves albuminuria in adults with type 1 diabetes and chronic kidney disease

1. In this phase 3 trial involving patients with type 1 diabetes and chronic kidney disease, finerenone was associated with significantly greater decreases in urinary albumin-to-creatinine ratio as compared to placebo. 2. Finerenone had an overall favorable safety profile but was associated with higher rates of hyperkalemia than placebo. Evidence Rating Level: 1 (Excellent) Study […] The post…